Edwards Lifesciences (EW)

EBITDA Growth

40.48%

Quarterly · Period ending:

EW logo

EW EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported40.48%
EW Quarterly EBITDA YoY % (28.94% → 40.48%)
High-resolution chart · PNG

EW ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences EBITDA Growth — Quarterly
Period endingEBITDA Growth
40.4798%
6.2487%
-72.4829%
-9.6082%
-6.1004%
14.8401%
19.7574%
1.013%
36.9537%
-5.5556%
-18.3546%
-4.1111%
-37.7475%
-8.0543%
20.5116%
3.7011%
-14.3714%
11.5366%
5.3374%
9.2654%
506.263%
8.7404%
14.8203%
20.2894%
-148.0441%
27.8344%
1,775.1381%
20.2963%
10.6139%
7.6787%
-94.7215%
16.129%
19.646%
-10.9079%
50.3288%
14.3068%
13.5678%
45.2381%
19.8004%
16.6954%
21.6381%
20.3969%
12.7962%
18.1695%
20.8272%
65.3601%
34.6093%
20.4082%
-4.1076%
-14.0282%
-9.4585%
12.6955%
34.3482%
27.7277%
64.2942%
49.931%
19.026%
0.3012%
-1.9767%
-9.7136%
9.2822%
24.812%
11.5435%
-27.3303%
3.3248%
-20.2%
81.4118%
90.1893%
15%
98.8072%
-28.088%
14.8221%
11.8421%
-13.2759%
2.4263%
-6.2963%
1.5025%
-27.6808%
-6.3312%
-0.1848%
-0.4983%
42.7046%
13.2353%
6.917%
12.3134%
55.6787%
7.2978%
15.5251%
26.4151%
-17.5799%
20.7143%
242.2078%
4.1769%
7.8818%
6.0606%
-189.5349%
212.1212%
-6.2356%
-34.6535%
-13.3501%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.